Pentagon Papers whistleblower prepares for end-of-life

United Kingdom News News

Pentagon Papers whistleblower prepares for end-of-life
United Kingdom Latest News,United Kingdom Headlines
  • 📰 TheRegister
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 61%

Pentagon whistleblower Ellsberg has months to live

Ellsberg has chosen not to undergo chemotherapy because it holds no promise for him. But he remains committed to advocating for peace."As I look back on the last sixty years of my life, I think there is no greater cause to which I could have dedicated my efforts," he wrote."Daniel Ellsberg is a national hero for blowing the whistle on a war that we should not have fought, and which our top leaders lied about to the American people," said Clark.

"Through his example, he paved the way for thousands of whistleblowers who similarly risk their careers and even freedom to disclose national security problems, health and safety dangers, violations of law, abuses of authority, and gross waste throughout government and within corporations. "In honor of his legacy, we must prevail upon Congress and state legislators to finally produce adequate legal protections for all whistleblowers in order to take the sacrifices of national security whistleblowers to heart."

This hack salutes the courage of those like Daniel Ellsberg who put themselves at risk for the sake of the truth. ®

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

TheRegister /  🏆 67. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Indian PM Narendra Modi's government resists recognition for same-sex marriage - court papersIndian PM Narendra Modi's government resists recognition for same-sex marriage - court papersGay sex was decriminalised in 2018 but the topic of same-sex marriage remains highly sensitive, with tensions running high before a Supreme Court hearing on Monday. Leaked documents suggest the government opposes legal recognition.
Read more »

Charity celebrates women empowerment course to teach vital life lessonsCharity celebrates women empowerment course to teach vital life lessonsA DRUMCHAPEL charity has celebrated its newly launched empowerment course for women with a string of events.
Read more »

Efficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial - BMC Complementary Medicine and TherapiesEfficacy and safety of topical 0.1% cannabidiol for managing recurrent aphthous ulcers: a randomized controlled trial - BMC Complementary Medicine and TherapiesBackground Although topical steroids constitute the first-line therapy for recurrent aphthous ulcers (RAUs), their long-term use often leads to candidiasis. Although cannabidiol (CBD) can be an alternative for pharmacologically managing RAUs due to its analgesic and anti-inflammatory in vivo effects, there is a lack of clinical and safety trials concerning its use. The aim of this study was to evaluate the clinical safety and efficacy of topical 0.1% CBD for managing RAU. Methods A CBD patch test was performed on 100 healthy subjects. CBD was applied on the normal oral mucosa of 50 healthy subjects 3 times/day for 7 days. Oral examination, vital signs, and blood tests were performed pre- and post-CBD use. Another 69 RAU subjects randomly received one of three topical interventions: 0.1% CBD, 0.1% triamcinolone acetonide (TA), or placebo. These were applied on the ulcers 3 times/day for 7 days. The ulcer and erythematous size were measured on day 0, 2, 5, and 7. Pain ratings were recorded daily. The subjects rated their satisfaction with the intervention and completed a quality-of-life questionnaire (OHIP-14). Results None of the subjects exhibited allergic reactions or side effects. Their vital signs and blood parameters were stable before and after the 7-day CBD intervention. CBD and TA significantly reduced ulcer size more than placebo at all time points. The erythematous size reduction was higher in the CBD intervention than the placebo on day 2, while TA reduced the erythematous size at all time points. The pain score in the CBD group was lower compared with placebo on day 5, whereas TA reduced pain more than placebo on day 4, 5, and 7. The subjects receiving CBD reported higher satisfaction than placebo. However, the OHIP-14 scores were comparable among the interventions. Conclusions Topical 0.1% CBD reduced ulcer size and accelerated ulcer healing without side effects. CBD exerted anti-inflammatory effects in the early stage and an analgesic effect in the late
Read more »

Major change to Universal Credit coming within weeks - check if you're affectedMajor change to Universal Credit coming within weeks - check if you're affectedTHOUSANDS of people claiming Universal Credit could see a change to their payments within weeks. It’s vital to take note of when you might get your payment so that you don’t fall short.…
Read more »

Oscar nominee Cate Blanchett on mum guilt and 'saying no' to projectsOscar nominee Cate Blanchett on mum guilt and 'saying no' to projectsCate Blanchett talks about her latest Oscar-nominated role in Tar, modern society and trying to reconcile work with family as she prepares to take a step back from acting commitments
Read more »



Render Time: 2025-02-24 07:48:54